Clinical Study of Dendrobium Nobile Lindl Intervention on Patients with Metabolic Syndrome

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2000003478

Enrollment

Unknown

Registered

2020-07-09

Start date

2020-07-13

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Interventions

experimental group:Dendrobium Nobile Powder

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 18-65 years of age, regardless of gender; 2. Meet Western medicine diagnostic criteria of metabolic syndrome; 3. Patients agreed to join this clinical study, voluntarily signed an informed consent form, and agreed to participate in all visits and inspections in accordance with the requirements of the study protocol.

Exclusion criteria

Exclusion criteria: 1. Pregnant or nursing women; 2. Patients with severe heart, liver and kidney dysfunction, tumors and other serious cerebrovascular diseases.

Design outcomes

Primary

Measure	Time frame
Blood Sugar;Lipids;	—

Secondary

Measure	Time frame
Weight;	—

Countries

China

Contacts

Public ContactMiao Wong

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

wangmiao_126@126.com+86 021-64385700

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026